TABLE II.
Clinical Outcomes Among Patients in Season 1 Versus Season 2
| Clinical outcomes | Season 1 (n=175) Median (range); n(%) |
Season 2 (n=175) Median (range); n(%) |
P-value |
|---|---|---|---|
| Influenza detecteda | 8 (5) | 32 (18) | <0.001 |
| Time to result in hoursb | 25.2 (2.7–55.9) | 1.7 (0.97–11.4) | <0.001 |
| Antibiotics administered for respiratory | 133 (76) | 110 (63) | 0.008 |
| illness or fevera | |||
| Influenza-positive | 5 (63) | 20 (63) | 1.00 |
| Influenza-negative | 128 (77) | 90 (63) | 0.01 |
| Days of hospitalizationb | 5 (0–117) | 4 (1–164) | 0.33 |
| Influenza-positive | 4 (1–11) | 4 (1–126) | 0.92 |
| Influenza-negative | 5 (0–117) | 5 (1–164) | 0.42 |
| Number of total patients started on oseltamivira |
79 (45) | 97 (55) | 0.05 |
| Influenza-positive | 8 (100) | 32 (100) | 1.00 |
| Influenza-negative | 71 (43) | 65 (45) | 0.60 |
| Doses of oseltamivir receivedb | 3 (1–23) | 2 (1–29) | 0.004 |
| Influenza-positive | 6.5 (4–23) | 6 (1–29) | 0.72 |
| Influenza-negative | 3 (1–8) | 1 (1–9) | <0.001 |
| Days of oseltamivir receivedb | 1.3 (0–9.4) | 0.36 (0–15.2) | <0.001 |
| Influenza-positive | 2.8 (0.98–9.4) | 2.4 (0–15.2) | 0.81 |
| Influenza-negative | 1.1 (0–4.7) | 0 (0–4.5) | <0.001 |
| Discharge antibiotic prescription for respiratory illnessa |
61 (35) | 49 (28) | 0.17 |
| Influenza-positive | 1 (13) | 9 (28) | 0.65 |
| Influenza-negative | 60 (24) | 40 (28) | 0.15 |
| Intensive care unit admissiona | 43 (25) | 55 (31) | 0.19 |
| Death due to respiratory illnessa | 4 (0.02) | 2 (0.01) | 0.68 |
a
Tested using Fisher’s exact or χ2 test.
b
Tested using Wilcoxon rank-sum test.